Skip to main content
Clinical Trials/NCT02618200
NCT02618200
Completed
Not Applicable

Creation of a Multimodality Image Database (MRI + Ultrasound) for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer

Hospices Civils de Lyon1 site in 1 country2 target enrollmentFebruary 1, 2016
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Hospices Civils de Lyon
Enrollment
2
Locations
1
Primary Endpoint
Obtention of 3D ultrasound images
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

Prostate cancer is currently detected by ultrasound-guided biopsy. Computer-aided diagnostic (CAD) systems based on multiparametric MRI are now capable of detecting most aggressive cancer foci non-invasively, but additional progress is needed for the technique to be accepted in clinical practice. We hypothesize that combining MRI and ultrasound imaging can improve the detection of cancerous tumors. As a first step in this direction, we need to create a database with MR images, 3D ultrasound images, and corresponding histopathology results, in patients treated by radical prostatectomy for prostate cancer. This is the purpose of the present study.

In a later stage (outside the scope of this study), we will be learning how to combine these images to best recognize cancerous tumors, we will use that knowledge to develop a new CAD system, and we will assess the performance of the new CAD. We expect this future system to improve the detection of prostate cancer and to reduce the number of patients requiring biopsy.

Registry
clinicaltrials.gov
Start Date
February 1, 2016
End Date
August 31, 2017
Last Updated
4 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient referred for radical prostatectomy
  • Patient with multiparametric prostate MRI (3T) performed in our institution (Edouard Herriot Hospital) in the year preceding the surgery
  • Informed consent signed
  • Patient affiliated to the French Health Insurance system

Exclusion Criteria

  • History of prostatic surgery or radiation therapy (prostatic or pelvic)
  • History of hormone therapy for prostate cancer
  • Previous surgery of the abdomino-perineal region, or other contraindication for transrectal ultrasound
  • Patient on protection of the court, under supervision or under trusteeship
  • Inability to express a consent

Outcomes

Primary Outcomes

Obtention of 3D ultrasound images

Time Frame: the day before radical prostatectomy

Study Sites (1)

Loading locations...

Similar Trials